|Bio - Pharmaceuticals SEZ
Government of India has granted ” in - principle approval “ to set up a Sector Specific Special Economic Zone for Pharmaceutical based on Biotechnology sector over an area of 365 hectares at Denkannikotta and Hosur Taluk, Krishnagiri District, Tamil Nadu by M/s BioPure Health Care Private Limited. The Company also proposed to extent the contiguous area to 1000 hectares (with additional area of 600 Hectares ) to make it as a multi-sector SEZ including health care segments under Phase II .
Thiru Rama Subramaniam and Thiru Vikram Viswanath are the key promoters of the project and have good track record as successful entrepreneurs with global exposure to project development and structuring and both are NRIs.
Major Constituents of the SEZ
Right from a US-FDA compliant Bio-Pharmaceuticals facility, Clinical Research Organization (CRO), JCAHO certified Hospital, Poison Control Centre, Centre for Regenerative Medicine, Associated research infrastructure be it a pathology lab or state of the art Medical Imagining and Tele-Medicine Research, logistics Hub etc, all the Integrated Health SEZ will have it all. Even though combined investment in the first phase in all these initiatives may exceed Rs.250 Crores, the project has the potential of transforming Hosur as a major Knowledge hub in the integrated health space. The key USP of this initiative will be its ability to attract world class professionals form diverse specializations (in the integrated Healthcare Space) into a single location.
The Site is located at about 11 Kms from the Chennai-Bangalore National Highways and is connected to the site by the State Highway Road. The Salem-Bangalore broad-gauge railway line passes close to the eastern boundary site. The HAL airport at Bangalore is about 47 Kms from the site and the proposed New Bangalore International Airport is about 90 Kms from the site.
The proposed SEZ when in operation is expected to provide employment opportunities for about 10,000 in ten years period of its operation.
Total project cost is estimated at Rs. 73.44 crores , The implementation and funding model is unique with a combination Venture Capital, Private Equity and Debt.